leadXpro
“We unlock tomorrow’s medicines together, better, faster.”
At leadXpro, we are committed to accelerating the discovery of life-changing medicines. Driven by our passion for innovation and cutting-edge science, we specialize in structure-based drug discovery, with a laser focus on membrane proteins. Working together with our clients, we aim to transform our science into therapies—better and faster.

Team




Founders

Gebhard Schertler
Membrane Protein Science Expert
Biochemist, group leader Structural Biology of Membrane Proteins at PSI. Previously member of the PSI Directorial Board.

Michael Hennig
CEO, Chairman of the Board
Structural biologist and senior drug discovery executive. Previously, global head of Discovery Technologies at Roche.

Rafael Abela
Board Member
Physicist, scientific advisor at PSI. Previously, scientific project leader for the SLS and SwissFEL projects at PSI, laboratory head at SLS and SwissFEL.
Board of Directors
Michael Milos
Board Member
Molecular biologist, University Vienna and Brain Research Institute at University Zürich, managing partner at AVANTECA Partners AG.
John Millard
Board Member
Serial entrepreneur, head of Technology Transfer Management at PSI, Swiss representative CERN KT Forum and board member of swiTT.
Andreas Insam
Board Member
Business economist, board member of XRnanotech, settlor INSAM Familienstiftung. Previously CEO of the BENDURA BANK in Liechtenstein.
- Michael Hennig as Chairman of the Board
- Rafael Abela as Board Member